Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.670
-0.100 (-5.65%)
Mar 3, 2026, 4:00 PM EST - Market closed
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
Research and Development of Its POZ Platform | 56.00K | 3.15M | 591.50K | 3.46M |
Research and Development of Its POZ Platform Growth | -98.22% | 433.05% | -82.93% | - |
| 56.00K | 3.15M | 591.50K | 3.46M |
| -98.22% | 433.05% | -82.93% | - |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 56.00K | 3.15M | 591.50K | 3.46M |
| -98.22% | 433.05% | -82.93% | - |
| 56.00K | 3.15M | 591.50K | 3.46M |
| -98.22% | 433.05% | -82.93% | - |
Source: S&P Global Market Intelligence.
